OSD contract manufacturing market valued at $54.7 billion by 2030
European Pharmaceutical Review
OCTOBER 7, 2022
A market report has projected that the global oral solid dosage (OSD) contract manufacturing market is expected to be worth $54.7 billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Leading companies in the oral solid dosage market are Catalent, Inc.,
Let's personalize your content